New consortium aims to expand patient access to life-saving oligonucleotide therapeutics
CPI is set to boost oligonucleotide manufacture through a £2.7 million 3‑year partnership with AstraZeneca, Novartis, and The University of Manchester.
Feb 28 2023
Blog
Meet the Team: Lara Picknett, Apprentice Scientist
Through my CPI degree-level apprenticeship, I’m developing skills that’ll last a lifetime, growing in confidence and working with diverse people.
Feb 06 2023
News
UKRI funding for innovative battery manufacturing projects destined to secure the future of electric vehicles
CPI will share £27.6 million in funding from UKRI’s Faraday Battery Challenge to deliver the next generation of batteries for electric vehicles.
Jan 30 2023
News
CPI Enterprises invests in wire harness automation SMEQ5D to support electric technologies
CPI Enterprises, the venture capital and investor engagement arm of CPI, has made its latest investment into Q5D – a leader in wire harness automation.
Jan 26 2023
News
One in five UK HealthTech SMEs head to US for product launch
Up to 24% of UK-based HealthTech SMEs launch their innovations in the US, rather than the UK, due to its market size and favourable regulatory environment.
Jan 11 2023
Blog
Top Moments of 2022
Discover how 2022 once again demonstrated how CPI adds real value to research, development impacting science and technology innovation.
Dec 16 2022
Blog
Five steps to a sustainable holiday season
Can innovation make Christmas more eco-friendly whilst keeping it jolly?
Dec 15 2022
Blog
The ABC of developing more sustainable materials
The world-leading partners we work with – including KCMC’s two new PIs at the University of Southampton – hold net-zero solutions in their hands.
Dec 14 2022
News
NeoVac and CPI partner to accelerate next-generation RNA vaccine technology to clinical trials
We’re helping NeoVac fast-track its lipid nanoparticle technology to clinical trials, to make RNA products more transportable, and have fewer side effects.
